Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1979457Generated: October 30, 2026

1-[1-(2-toluoylmethyl)-2-oxo-5-(2-thenoyl)-8-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-3-yl]-3-(3-tert-butoxycarbonylphenyl)urea → 3-[3-[1-(2-toluoylmethyl)-2-oxo-5-(2-thenoyl)-8-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-3-yl]ureido]benzoic acid

https://huagongshe.com/reaction/1979457

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-[1-(2-toluoylmethyl)-2-oxo-5-(2-thenoyl)-8-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-3-yl]-3-(3-tert-butoxycarbonylphenyl)ureaHCID 21201627—
SolventTrifluoroacetic acidHCID 6422—
Product3-[3-[1-(2-toluoylmethyl)-2-oxo-5-(2-thenoyl)-8-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-3-yl]ureido]benzoic acidHCID 2120171499.3%

Reaction Steps

1-[1-(2-Toluoylmethyl)-2-oxo-5-(2-thenoyl)-8-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-3-yl]-3-(3-tert-butoxycarbonylphenyl)urea (3.35 g) was dissolved in trifluoroacetic acid (30 ml), and then stirred for one hour at room temperature. The reaction mixture was concentrated under reduced pressure, hexane was added to the residue for trituration, and collected by filtration, to thereby obtain 3.04 g of the title compound as colorless powder (Yield: 99%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06239131B1
Source datasetuspto-grants-2001_05
ORD IDord-2020197cf4214ca388dda8c3845395b0
Source noteuspto-grants-2001_05